Ariad Pharmaceuticals, Inc. Names Timothy P. Clackson to New Position of President of Research and Development

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Timothy P. Clackson, Ph.D. has been named the company’s first President of Research and Development, effective immediately. Dr. Clackson, who joined ARIAD in 1994, also retains his position as Chief Scientific Officer.
MORE ON THIS TOPIC